Fund moves
6.2%Stake
A Schedule 13D means the holder owns more than 5% and keeps the option to push for changes: board seats, a sale, buybacks. It must be filed within 5 business days.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Oct 12, 2026 · Filed Oct 14, 2026
Sophia Genetics's Executive Chairman sold $62K of Sophia Genetics shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$61,671
Shares × reported transaction price
Closed at $7.22 on Oct 12, 2026, 86% above its 52-week low and 19% below its high, after an 11% drop over the previous 30 trading days
52-week range $3.89 (Nov 20, 2025) to $8.92 (Aug 27, 2026), 66% of the way up, from 250 adjusted closes. 30 trading days earlier: $8.14 on Aug 28, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −3.3% | −1.0% | −2.3% |
Past results only. Not a forecast.
Fund moves
A Schedule 13D means the holder owns more than 5% and keeps the option to push for changes: board seats, a sale, buybacks. It must be filed within 5 business days.
Well Daan Van (Chief Legal Officer) sold ~$10K of Sophia Genetics
Planned saleJurgi Camblong (Executive Chairman) sold ~$66K of Sophia Genetics
Planned saleEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.